GW Pharmaceuticals Flying High into Huge Gains

What happened

GW Pharmaceuticals (NASDAQ: GWPH) stock rocketed 77% higher in the first half of 2019 (January through June), according to data from S&P Global Market Intelligence. It was flat during the holiday-shortened first week of July, so its year-to-date 2019 gain is also about 77%.

For context, the S&P 500 index returned 18.5% in the first six months of the year, and has returned 20.6% so far this year through July 5.

The British biopharmaceutical company develops prescription drugs derived from cannabinoids, chemical substances found in marijuana.

So what

GW Pharmaceuticals stock's year-to-date gain came in the first two months of the year, as shares were up 76.6% over this period. They've mostly traded in a moderately tight trading range since then.

In January, shares surged more than 46%, though there didn't appear to be any specific news to account for this big gain. As I previously wrote:

“We can probably attribute the stock's strong performance [in January] largely to the enthusiasm surrounding the overall cannabis sector. Nearly all cannabis stocks soared in January, with Canadian grower Canopy Growth, the largest cannabis stock by market cap, skyrocketing 82.3%.”

Read the full article at Yahoo Finance.

Don’t Stop Here

More To Explore

The Hottest Graphene Stocks To Watch In 2025

Forbes predicts this may be the next “multibillion-dollar material”… while Bloomberg says “this material will change the world”. The biggest technological advances in the future

Top Graphene Stocks For 2025

Graphene is an excellent conductor of electricity and heat, surpassing traditional materials like silicon, and it possesses exceptional mechanical strength, being hundreds of times stronger